#pricing

The state would pay a fixed annual amount for an unlimited supply of HCV drugs for its Medicaid program.

The increases will disproportionately affect people living with costly conditions like heart disease, cancer, diabetes and hepatitis C.

New treatments for the hepatitis C virus may have cure rates nearing 100 percent, but one global liver disease expert believes the fight again...

The high price of Sovaldi is seriously threatening the budgets of both federal agencies.

The U.S. Senate held another special meeting to look into the high costs of hepatitis C virus (HCV) treatment and to discuss the government’s...

The lawsuit is seeking class action status on behalf of all people and organizations who have paid all or some of the current purchase price f...

The National Health Service would be reimbursed if patients failed to clear HCV.

The FPC argues that setting a flat price would help ensure patients needing longer treatments would not be restricted from taking the new hep...

Gilead has not yet revealed the exact cost, but financial experts predict pricing between $85,000 and $100,000 per patient.

The president and CEO of Blue Cross and Blue Shield of Louisiana on sustainable hepatitis drug pricing.

About 225,000 to 330,000 Americans are currently coinfected with both HIV and hepatitis C.

An estimated 17 percent of all U.S. inmates are currently infected.

Public documents from 2011 show that Pharmasset, the original developer of Sovaldi, initially estimated a price of $36,000 for the treatment.

The country currently has the highest prevalence of hepatitis C in the world.

The reporter, editor and university professor behind Nebraska’s Rural Health News Service on sparking a national conversation about the...

A new story by Kaiser Health News and the Washington Post asks: ’Should pricey new treatments for the hepatitis C virus be limited to the sick...